3.8 Review

Understanding breast cancer - The long and winding road

Journal

BBA CLINICAL
Volume 7, Issue -, Pages 64-77

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbacli.2017.01.001

Keywords

Breast cancer; Hippocrates; Tamoxifen; Angelina Jolie; Herceptin; Radical mastectomy; Mammography; Aromatase inhibitors; BRCA1 and BRCA2; ER; HER2; Triple negative breast cancer (TNBC)

Funding

  1. Canadian Breast Cancer Foundation (CBCF) [416170]
  2. Canadian Institutes of Health Research (CIHR) [411333]

Ask authors/readers for more resources

Background: Despite a remarkable increase in the depth of our understanding and management of breast cancer in the past 50 years, the disease is still amajor public health problemworldwide and poses significant challenges. The palpability of breast tumors has facilitated diagnosis and documentation since ancient times. The earliest descriptions of breast cancer date back to around 3500 BCE. For centuries to follow, theories by Hippocrates (460 BCE) and Galen (200 CE), attributing the cause of breast cancer to an excess of black bile and treatment options including the use of opiumand castor oil, prevailed. Surgical resectionwas introduced in the 18th century. The advent of modern medicine led to the development of novel treatment options that include hormonal, targeted and chemo-therapies. There are still several therapeutic challenges including the treatment of triple negative breast cancer (TNBC), and overcoming drug resistance. Scope of review: The increased incidence and awareness of breast cancer has led to significant changes in diagnosis and treatment in recent decades. But, mankind has come a long way. Herein, I have traced how our understanding of breast cancer has evolved from the early description of the disease around 460 BCE as black bile-containing crab-like tumors to the conventional as a heterogeneous disease with high degree of diversity between and within tumors, as well as among breast cancer patients. How is breast cancer treated today and how do risk factors, breast cancer subtype and drug resistance contribute to the therapeutic challenges at the turn of the 21st century? Major conclusions: Breast cancer remains a serious public health issue worldwide. However, appreciable growth in our understanding of breast cancer in the past century has led to remarkable progress in the early detection, treatment and prevention of the disease. The clinical focus is shiftingmore towards tailored therapy asmore targets are characterized and novel highly innovative approaches are developed. General significance: Tracing the history of breast cancer, highlights how increased awareness of the disease, and progress in research and development have enhance our understanding of the disease. (C) 2017 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available